Renalytix Ai Stock EBITDA
Renalytix AI fundamentals help investors to digest information that contributes to Renalytix's financial success or failures. It also enables traders to predict the movement of Renalytix Stock. The fundamental analysis module provides a way to measure Renalytix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Renalytix stock.
Renalytix |
Renalytix AI Company EBITDA Analysis
Renalytix's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Renalytix EBITDA | (28.52 M) |
Most of Renalytix's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Renalytix AI is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Renalytix AI reported earnings before interest,tax, depreciation and amortization of (28.52 Million). This is 103.25% lower than that of the Health Care Technology sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is 100.73% higher than that of the company.
Renalytix EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Renalytix's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Renalytix could also be used in its relative valuation, which is a method of valuing Renalytix by comparing valuation metrics of similar companies.Renalytix is currently under evaluation in ebitda category among its peers.
Renalytix Fundamentals
| Return On Equity | -10.73 | |||
| Return On Asset | -0.94 | |||
| Operating Margin | (9.43) % | |||
| Current Valuation | 36.84 M | |||
| Shares Outstanding | 82.96 M | |||
| Shares Owned By Insiders | 4.51 % | |||
| Shares Owned By Institutions | 4.13 % | |||
| Number Of Shares Shorted | 378.92 K | |||
| Price To Book | 18.77 X | |||
| Price To Sales | 9.85 X | |||
| Revenue | 2.29 M | |||
| Gross Profit | 720 K | |||
| EBITDA | (28.52 M) | |||
| Net Income | (33.46 M) | |||
| Cash And Equivalents | 32.36 M | |||
| Cash Per Share | 0.89 X | |||
| Total Debt | 8.54 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 2.48 X | |||
| Book Value Per Share | (0.05) X | |||
| Cash Flow From Operations | (30.11 M) | |||
| Short Ratio | 0.39 X | |||
| Earnings Per Share | (0.62) X | |||
| Target Price | 2.5 | |||
| Beta | 2.1 | |||
| Market Capitalization | 22.55 M | |||
| Total Asset | 7.97 M | |||
| Retained Earnings | (211.78 M) | |||
| Working Capital | 12.2 M | |||
| Net Asset | 7.97 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Renalytix Stock
If you are still planning to invest in Renalytix AI check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Renalytix's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |